Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | VIB305 |
| Synonyms | |
| Therapy Description |
Limited information is currently available on VIB305, a putative T-cell engager targeting EGFR (Apr 2026). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| VIB305 | VIB-305|VIB 305 | Limited information is currently available on VIB305, a putative T-cell engager targeting EGFR (Apr 2026). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07222969 | Phase Ib/II | VIB305 | A Clinical Study to Evaluate the Safety of VIB305 in Patients With Advanced Solid Tumors | Recruiting | AUS | 1 |